Apimeds pharmaceuticals us, incAPUS.US Overview

US StockHealthcare

(No presentation for APUS)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

APUS Overall Performance

APUS AI Analysis & Strategy

APUS Recent Performance

-3.94%

Apimeds pharmaceuticals us, inc

0.81%

Avg of Sector

-1.14%

S&P500

APUS PowerScanner

APUS Key Information

APUS Valuation Metrics

APUS Earnings Table

APUS Profile

Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, an active pharmaceutical ingredient for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Hopewell, New Jersey. Apimeds Pharmaceuticals US, Inc. is a subsidiary of Api Meds, Inc.